Primary sclerosing cholangitis epidemiology and demographics: Difference between revisions
Dima Nimri (talk | contribs) No edit summary |
Dima Nimri (talk | contribs) |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
==Epidemiology | ==Epidemiology== | ||
===Incidence=== | ===Incidence=== | ||
===Prevalence=== | ===Prevalence=== | ||
=== | |||
==Demographics== | |||
===Age=== | |||
===Gender=== | |||
===Race=== | |||
==References== | ==References== |
Revision as of 19:04, 8 December 2016
Primary sclerosing cholangitis Microchapters |
Differentiating Primary sclerosing cholangitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary sclerosing cholangitis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Primary sclerosing cholangitis epidemiology and demographics |
FDA on Primary sclerosing cholangitis epidemiology and demographics |
CDC on Primary sclerosing cholangitis epidemiology and demographics |
Primary sclerosing cholangitis epidemiology and demographics in the news |
Blogs on Primary sclerosing cholangitis epidemiology and demographics |
Directions to Hospitals Treating Primary sclerosing cholangitis |
Risk calculators and risk factors for Primary sclerosing cholangitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Epidemiology
Incidence
Prevalence
Demographics
Age
Gender
Race
References